New merciful treatment method for children with brain tumors

October 15, 2012

Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus – the part of the brain involved in memory and learning.

Researchers at the University of Gothenburg's Sahlgrenska Academy have used a model study to test newer radiation therapy techniques which could reduce these harmful adverse effects. The researchers based their study on a number of paediatric patients who had undergone conventional radiation treatment for medulloblastoma, a form of that almost exclusively affects children, and simulated treatment plans using proton therapy techniques and newer photon therapy techniques.

Each treatment plan was personalised by physician Malin Blomstrand, physicist Patrik Brodin and their colleagues. The results show that the risk of neurocognitive adverse effects can be reduced significantly using the new radiation treatment techniques, particularly .

"This could mean a better quality of life for children who are forced to undergo therapy," says Malin Blomstrand.

Explore further: Study examines adverse effects among different radiation therapies for prostate cancer

More information: The article "Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma" will be published in the journal Neuro-Oncology.

Related Stories

Recommended for you

Study offers guidance for targeting residual ovarian tumors

May 23, 2017

Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. ...

Antibody for fighting cancer emerges

May 19, 2017

While studying the underpinnings of multiple sclerosis, investigators at Brigham and Women's Hospital came across important clues for how to treat a very different disease: cancer. In a paper published in Science Immunology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.